Rhabdomyoma: Difference between revisions

Jump to navigation Jump to search
Line 70: Line 70:
====Immunohistochemistry====
====Immunohistochemistry====
*Immunohistological cell markers include:
*Immunohistological cell markers include:
**[[muscle]] specific [[actin]], [[phosphotungstic acid hematoxylin]] ([[PTAH]]), [[desmin]], and [[myoglobin]].<ref name="pmid16419079">{{cite journal |vauthors=Bjørndal Sørensen K, Godballe C, Ostergaard B, Krogdahl A |title=Adult extracardiac rhabdomyoma: light and immunohistochemical studies of two cases in the parapharyngeal space |journal=Head Neck |volume=28 |issue=3 |pages=275–9 |date=March 2006 |pmid=16419079 |doi=10.1002/hed.20358 |url=}}</ref>
**[[Muscle]] specific [[actin]], [[phosphotungstic acid hematoxylin]] ([[PTAH]]), [[desmin]], and [[myoglobin]].<ref name="pmid16419079">{{cite journal |vauthors=Bjørndal Sørensen K, Godballe C, Ostergaard B, Krogdahl A |title=Adult extracardiac rhabdomyoma: light and immunohistochemical studies of two cases in the parapharyngeal space |journal=Head Neck |volume=28 |issue=3 |pages=275–9 |date=March 2006 |pmid=16419079 |doi=10.1002/hed.20358 |url=}}</ref>
**[[Dystrophin]] is shown to be expressed in the cell membranes.
**[[Dystrophin]] is shown to be expressed in the cell membranes.



Revision as of 18:34, 13 December 2018

WikiDoc Resources for Rhabdomyoma

Articles

Most recent articles on Rhabdomyoma

Most cited articles on Rhabdomyoma

Review articles on Rhabdomyoma

Articles on Rhabdomyoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Rhabdomyoma

Images of Rhabdomyoma

Photos of Rhabdomyoma

Podcasts & MP3s on Rhabdomyoma

Videos on Rhabdomyoma

Evidence Based Medicine

Cochrane Collaboration on Rhabdomyoma

Bandolier on Rhabdomyoma

TRIP on Rhabdomyoma

Clinical Trials

Ongoing Trials on Rhabdomyoma at Clinical Trials.gov

Trial results on Rhabdomyoma

Clinical Trials on Rhabdomyoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Rhabdomyoma

NICE Guidance on Rhabdomyoma

NHS PRODIGY Guidance

FDA on Rhabdomyoma

CDC on Rhabdomyoma

Books

Books on Rhabdomyoma

News

Rhabdomyoma in the news

Be alerted to news on Rhabdomyoma

News trends on Rhabdomyoma

Commentary

Blogs on Rhabdomyoma

Definitions

Definitions of Rhabdomyoma

Patient Resources / Community

Patient resources on Rhabdomyoma

Discussion groups on Rhabdomyoma

Patient Handouts on Rhabdomyoma

Directions to Hospitals Treating Rhabdomyoma

Risk calculators and risk factors for Rhabdomyoma

Healthcare Provider Resources

Symptoms of Rhabdomyoma

Causes & Risk Factors for Rhabdomyoma

Diagnostic studies for Rhabdomyoma

Treatment of Rhabdomyoma

Continuing Medical Education (CME)

CME Programs on Rhabdomyoma

International

Rhabdomyoma en Espanol

Rhabdomyoma en Francais

Business

Rhabdomyoma in the Marketplace

Patents on Rhabdomyoma

Experimental / Informatics

List of terms related to Rhabdomyoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2] Simrat Sarai, M.D. [3]

Synonyms and keywords: Rhabdomyomatous neoplasm; Adult rhabdomyoma; Genital rhabdomyoma; Fetal rhabdomyoma

Overview

A rhabdomyoma is a benign tumor of striated muscle. Rhabdomyomas develop mostly before the age of one year, almost exclusively in children, and approximately 80 to 90 percent are associated with tuberous sclerosis. The most common primary benign pediatric tumor of the heart is cardiac rhabdomyoma which can be seen mainly in fetal life and children, second most common primary benign cardiac tumor in children is fibroma. Most tumors regress spontaneously, prognosis depends on location of tumor and size. Cardiac rhabdomyoma are strongly associated with tuberous sclerosis and some other anomalies.

Classification

  • Cardiac rhabdomyoma
  • Rhabdomyomatous mesenchymal hamartomas of the skin(RMH) which is a rare congenital malformation involving the dermis and subcutaneous tissue, it can present as skin tag or even trigeminal neualgia case reported. [7]

Staging

The staging of rhabdomyomas is based on the grade (G), site (T), and metastasis (M), as follows:

  • G0 - Benign
  • T0 - Intracapsular
  • T1 - Extracapsular, intracompartmental
  • M0 - None
Stage Severity Description
Benign Stage 1
  • Latent G0T0M0
  • Remains static or heals spontaneously
Benign Stage 2
  • Active G0T0M0
  • Progressive growth but limited by natural barriers
Benign Stage 3
  • Aggressive G0T1M0
  • Progressive growth not limited by natural barriers

Pathophysiology

Pathogenesis

  • Cardiac rhabdomyoma is usually diagnosed during the second or third trimester on ultrasound, rhabdomyoma appears as round, homogeneous, hyperechogenic masses in the ventricles, and they sometimes appear as multiple foci in the ventricles and septal wall. Differential diagnosis between rhabdomyoma, fibroma or myxoma using ultrasonography for a single cardiac mass remains difficult. [8]
  • Cells usually lose their ability to divide and undergo apoptosis via a ubiquitin-mediated pathway and regression of the hamartoma ensues.[9]
  • Complete or partial resolution occurs in the majority of cases, regardless of the initial size of the tumor.

Location

Immunohistochemistry

Associated Conditions

Gross Pathology

  • On gross pathology, round or polypoid mass in the region of the neck are characteristic findings of adult rhabdomyoma.
    • Round or lobulated, grossly well-circumscribed masses which range from 1 mm to 10 cm in their greatest dimension.
    • Isolated or multiple.
    • Solid tan-white homogeneous consistency, often watery and glistening on their cut surface.
    • Infrequently, calcification and hemorrhage.
Cardiac rhabdomyoma Gross. Source: http://peir2.path.uab.edu/pdl/dbra.cgi?uid=default&view_search=1


Microscopic Pathology

  • On microscopic histopathological analysis, characteristic findings of adult rhabdomyoma include:
    • Polygonal cells with eosinophilic granular cytoplasm that are mixed with intracellular vacuolated cells.
    • Rhabdomyomas are very well differentiated similarly to striated muscle cells which present markers such as actin, desmin, and myoglobin; dystrophin on their cell membranes. [12]
  • Histopathologic findings of fetal rhabdomyoma include spindle-shaped cells with vacuolated cytoplasm and muscle fibers.
  • On microscopic histopathological analysis, characteristic findings of genital rhabdomyoma include:
    • fibroblast cells among them mature striated cells.
    • A matrix containing varying amounts of collagen and mucoid material
  • On microscopic histopathological analysis, characteristic findings of cardiac rhabdomyoma include cells that closely resemble embryonic cardiac muscle cells.
  • On microscopic histopathological findings of Rhabdomyomatous mesenchymal hamartoma (RMH) which is a rare congenital lesion of the dermis and soft tissues consisting of a disordered and varied collection of mature adipose tissue, skeletal muscle, adnexal elements and nerve bundles. This entity exists under various names including striated muscle hamartoma, congenital midline hamartoma, and hamartoma of cutaneous adnexa and mesenchyme. Several published cases report the occurrence of RMH within the setting of other uncommon congenital abnormalities.[12]
fetal rhabdomyoma H&E stain [https:https://en.wikipedia.org/wiki/Rhabdomyoma#/media/File:Fetal_intermediate_cellular_type_rhabdomyoma.JPG source:Jerad M Gardner, MD]


Causes

  • Adult rhabdomyomas are matured neoplasms of clonal origin.
  • Cardiac rhabdomyoma may be caused by either sporadic mutation or in the setting of certain genetic disorders.[13]
  • The genetic disorder commonly associated with cardiac rhabdomyoma is tuberous sclerosis.[14] Other genetic disorders associated with cardiac rhabdomyomas include basal cell nevus syndrome and Down syndrome in the setting of tuberous sclerosis.[15][16]
  • The familial form of tuberous sclerosis are hamartomas that can involve the kidneys, heart, skin, brain, and other organs.
  • Cardiac rhabdomyoma can be the only presenting sign of tuberous sclerosis and there are strongly related, in fact, tuberous sclerosis in a fetus can be detected as cardiac rhabdomyoma on ultrasound.[8]
  • Molecular evidence of this association has been identified as the TSC2 gene missense mutation.
  • Cardiac rhabdomyoma is caused by a mutation in the TSC-1 on chromosome 9q34 that encodes for protein hamartin, and TSC-2 on 16p13 that encodes for tuberin. These genes are both tumor suppressor genes that assist in the regulation of growth and differentiation of developing cardiomyocytes[17]

Differentiating Rhabdomyoma from Other Diseases

  • Rhabdomyomas must be differentiated from other diseases, such as:[18]

Epidemiology and Demographics

  • Cardiac rhabdomyomas are usually detected during the first year of life or before birth and accounts for majority of all primary cardiac tumors.
  • Worldwide, rhabdomyoma is rare.
  • Most of patients with tuberous sclerosis develop a cardiac rhabdomyoma. Similarly, children diagnosed with cardiac rhabdomyomas demonstrate radiologic or clinical findings of tuberous sclerosis or have a positive family history. Rhabdomyoma is extremely rare in the United States. Rhabdomyoma has a relative incidence of 5.8%. The incidence of cardiac rhabdomyoma is 0.002-0.25% at autopsy, 0.02-0.08% in live-born infants, and 0.12% in prenatal reviews.[15][19][20]

Age

  • Adult rhabdomyoma is more commonly observed among patients aged greater than 40 years old.[21]
  • Fetal rhabdomyoma is more commonly observed among patients aged between birth and 3 years.
  • Cardiac rhabdomyoma is more commonly observed among patients in the pediatric age group.
  • Genital rhabdomyoma is more commonly observed among patients in the young and middle-aged women.
  • Rhabdomyomatous mesenchymal hamartomas of the skin is more commonly observed among newborns and infants.[1]

Gender

  • Cardiac rhabdomyoma affects men and women equally.
  • Rhabdomyomatous mesenchymal hamartoma of skin is observed in male and female newborns and infants equally.
  • Males are more commonly affected with adult rhabdomyoma than females.
  • Males are more commonly affected with fetal rhabdomyoma than females.
  • Females are more commonly affected with genital rhabdomyoma than males.

Race

  • There is no racial predilection for rhabdomyomas.

Risk Factors

  • There are no established risk factors for rhabdomyoma.

Natural History, Complications and Prognosis

Natural History

Complications

Prognosis

  • prognosis is generally good; the survival rate of patients with benign rhabdomyoma is excellent, depending on location of tumor, prognosis may change.[24]
  • Rhabdomyomas on mitral or tricuspid valves can lead to regurgitation or obstruction of outflow tract thus poor prognosis.[25]
  • The long-term prognosis of cardiac rhabdomyoma is affected by the neurologic manifestations associated with tuberous sclerosis.[26]
  • The prognosis of patients with rhabdomyomas depends mainly on the size, location, number of the lesions, associated anomalies such as tuberous sclerosis.
  • Metastases have not been associated with rhabdomyoma.

Diagnosis

Symptoms

  • Symptoms of adult rhabdomyoma may include:
  • Symptoms of genital rhabdomyoma may include the following:
  • Symptoms of cardiac rhabdomyoma may include the following:

Physical Examination

Laboratory Findings

Imaging Findings

  • MRI is the imaging modality of choice for rhabdomyoma. Chest CT scan may be helpful in the diagnosis of cardiac rhabdomyoma.
  • On ultrasound, rhabdomyoma is characterized by one or more solid hyper echoic mass(es) located in relation to the myocardium. The small lesions can mimic diffuse myocardial thickening.
  • X-Rays of the chest and affected areas of the body may be helpful in the diagnosis of rhabdomyomas.[31]
fetal cardiac rhabdomyoma source:Case courtesy of Dr Effendi Mansoor, <a href="https://radiopaedia.org/">Radiopaedia.org</a>. From the case <a href="https://radiopaedia.org/cases/17302">rID: 17302</a>


Other Diagnostic Studies

  • Rhabdomyoma may also be diagnosed using biopsy since overlap in morphologic features between rhabdomyosarcoma (RMS) vs. rhabdomyoma makes differential diagnosis difficult.[32]
  • Any masses, including those found in the head and neck of patients with adult rhabdomyoma, should be biopsied to establish a diagnosis.

Treatment

Medical Therapy

Adult rhabdomyoma

  • Patients with laryngeal rhabdomyoma need immediate care such as nasal oxygen, intravenous fluids and if respiratory distress develops intubation before admission for surgery and surgical excision. [36]
  • Patients with adult rhabdomyoma and shortness of breath should restrain from activities which exacerbate their breathing difficulty.

Cardiac rhabdomyoma

  • Pharmacological treatment available for fetal cardiac rhabdomyoma is everolimus.
  • Patients with arrhythmias are treated with antiarrhythmic medications.
  • Restriction on physical activities in those patients with cardiac clinical symptoms.
  • Asymptomatic children with TSC and a rhabdomyoma should have echocardiography every one to three years until regression of cardiac rhabdomyoma is documented.

Genital rhabdomyoma

Surgery

Adult rhabdomyoma

  • Surgical resection of the tumor can only be performed for patients with adult rhabdomyoma if airway obstruction is diagnosed, there have been reports of rare cases of laryngeal rhabdomyoma which may cause breathing difficulty for patients.[38]

Cardiac rhabdomyoma

  • In patients with cardiac rhabdomyoma who have symptoms of severe outflow tract obstruction or arrhythmias, surgical intervention can be helpful. Surgical management involves removal of the part of the tumor causing obstruction without complete excision of the entire lesion.[39]

Prevention

  • There are no primary preventive measures available for rhabdomyoma.

References

  1. 1.0 1.1 McKinnon EL, Rand AJ, Selim MA, Fuchs HE, Buckley AF, Cummings TJ (October 2015). "Rhabdomyomatous mesenchymal hamartoma presenting as a sacral skin tag in two neonates with spinal dysraphism". J. Cutan. Pathol. 42 (10): 774–8. doi:10.1111/cup.12538. PMID 25989364.
  2. Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM (1997). "Pediatric primary benign cardiac tumors: a 15-year review". Am Heart J. 134 (6): 1107–14. PMID 9424072.
  3. 3.0 3.1 Becker AE (2000). "Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians". Pediatr Cardiol. 21 (4): 317–23. doi:10.1007/s002460010071. PMID 10865004.
  4. Elderkin RA, Radford DJ (2002). "Primary cardiac tumours in a paediatric population". J Paediatr Child Health. 38 (2): 173–7. PMID 12031001.
  5. Kocabaş A, Ekici F, Cetin Iİ, Emir S, Demir HA, Arı ME; et al. (2013). "Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome". Pediatr Hematol Oncol. 30 (2): 71–9. doi:10.3109/08880018.2012.734896. PMID 23151153.
  6. 6.0 6.1 Lu DY, Chang S, Cook H, Alizadeh Y, Karam AK, Moatamed NA, Dry SM (April 2012). "Genital rhabdomyoma of the urethra in an infant girl". Hum. Pathol. 43 (4): 597–600. doi:10.1016/j.humpath.2011.06.012. PMID 21992817.
  7. White LR, Agrawal V, Sutton L, Balbosa AC (June 2015). "Rhabdomyomatous mesenchymal hamartoma of the face causing trigeminal neuralgia". Am J Case Rep. 16: 338–40. doi:10.12659/AJCR.893719. PMC 4460909. PMID 26037964.
  8. 8.0 8.1 Sharma N, Sharma S, Thiek JL, Ahanthem SS, Kalita A, Lynser D (2017). "Maternal and Fetal Tuberous Sclerosis: Do We Know Enough as an Obstetrician?". J Reprod Infertil. 18 (2 pages=257–260). PMC 5565905. PMID 28868251.
  9. Wu SS, Collins MH, de Chadarévian JP (2002). "Study of the regression process in cardiac rhabdomyomas". Pediatr. Dev. Pathol. 5 (1): 29–36. PMID 11815866.
  10. 10.0 10.1 Bjørndal Sørensen K, Godballe C, Ostergaard B, Krogdahl A (March 2006). "Adult extracardiac rhabdomyoma: light and immunohistochemical studies of two cases in the parapharyngeal space". Head Neck. 28 (3): 275–9. doi:10.1002/hed.20358. PMID 16419079.
  11. Castilla Cabanes E, Lacambra Blasco I (2014). "Multiple cardiac rhabdomyomas, wolff-Parkinson-white syndrome, and tuberous sclerosis: an infrequent combination". Case Rep Pediatr. 2014: 973040. doi:10.1155/2014/973040. PMC 4189844. PMID 25328743.
  12. 12.0 12.1 Rosenberg AS, Kirk J, Morgan MB (April 2002). "Rhabdomyomatous mesenchymal hamartoma: an unusual dermal entity with a report of two cases and a review of the literature". J. Cutan. Pathol. 29 (4): 238–43. PMID 12028157.
  13. Burke A, Virmani R (2008). "Pediatric heart tumors". Cardiovasc Pathol. 17 (4): 193–8. doi:10.1016/j.carpath.2007.08.008. PMID 18402818.
  14. Vaughan CJ, Veugelers M, Basson CT (2001). "Tumors and the heart: molecular genetic advances". Curr Opin Cardiol. 16 (3): 195–200. PMID 11357016.
  15. 15.0 15.1 Isaacs H (2004). "Fetal and neonatal cardiac tumors". Pediatr Cardiol. 25 (3): 252–73. doi:10.1007/s00246-003-0590-4. PMID 15360117.
  16. Krapp M, Baschat AA, Gembruch U, Gloeckner K, Schwinger E, Reusche E (1999). "Tuberous sclerosis with intracardiac rhabdomyoma in a fetus with trisomy 21: case report and review of literature". Prenat Diagn. 19 (7): 610–3. PMID 10419607.
  17. Goldenberg DL (November 1989). "A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome". J Rheumatol Suppl. 19: 137–9. PMID 2691673.
  18. Nasr E, Ibrahim M, Yacoub M (January 2017). "Heart failure in a neonate with multiple cardiac masses". Heart. 103 (1): 18. doi:10.1136/heartjnl-2016-310251. PMID 27655257.
  19. Delides A, Petrides N, Banis K (2005). "Multifocal adult rhabdomyoma of the head and neck: a case report and literature review". Eur Arch Otorhinolaryngol. 262 (6): 504–6. doi:10.1007/s00405-004-0840-y. PMID 15942804.
  20. Ramadani N, Kreshnike KD, Muçaj S, Kabashi S, Hoxhaj A, Jerliu N, Bejiçi R (April 2016). "MRI Verification of a Case of Huge Infantile Rhabdomyoma". Acta Inform Med. 24 (2): 146–8. doi:10.5455/aim.2016.24.146-148. PMC 4851540. PMID 27147810.
  21. Bejiqi R, Retkoceri R, Bejiqi H (April 2017). "Prenatally Diagnosis and Outcome of Fetuses with Cardiac Rhabdomyoma - Single Centre Experience". Open Access Maced J Med Sci. 5 (2): 193–196. doi:10.3889/oamjms.2017.040. PMC 5420773. PMID 28507627.
  22. Barnes BT, Procaccini D, Crino J, Blakemore K, Sekar P, Sagaser KG, Jelin AC, Gaur L (May 2018). "Maternal Sirolimus Therapy for Fetal Cardiac Rhabdomyomas". N. Engl. J. Med. 378 (19): 1844–1845. doi:10.1056/NEJMc1800352. PMC 6201692. PMID 29742370.
  23. Smythe JF, Dyck JD, Smallhorn JF, Freedom RM (1990). "Natural history of cardiac rhabdomyoma in infancy and childhood". Am J Cardiol. 66 (17): 1247–9. PMID 2239731.
  24. Linnemeier L, Benneyworth BD, Turrentine M, Rodefeld M, Brown J (April 2015). "Pediatric cardiac tumors: a 45-year, single-institution review". World J Pediatr Congenit Heart Surg. 6 (2): 215–9. doi:10.1177/2150135114563938. PMID 25870340.
  25. Wang Y, Wang X, Xiao Y (February 2016). "Surgical treatment of primary cardiac valve tumor: early and late results in eight patients". J Cardiothorac Surg. 11: 31. doi:10.1186/s13019-016-0406-2. PMC 4759914. PMID 26891966.
  26. Chung C, Lawson JA, Sarkozy V, Riney K, Wargon O, Shand AW, Cooper S, King H, Kennedy SE, Mowat D (November 2017). "Early Detection of Tuberous Sclerosis Complex: An Opportunity for Improved Neurodevelopmental Outcome". Pediatr. Neurol. 76: 20–26. doi:10.1016/j.pediatrneurol.2017.05.014. PMID 28811058. Vancouver style error: initials (help)
  27. Lee JP, Blake Sullivan C, Bayon R, Shearer AE, Robinson RA (December 2018). "Adult type rhabdomyoma presenting as a parathyroid adenoma". Head Neck. doi:10.1002/hed.25419. PMID 30537102.
  28. Bosi G, Lintermans JP, Pellegrino PA, Svaluto-Moreolo G, Vliers A (1996). "The natural history of cardiac rhabdomyoma with and without tuberous sclerosis". Acta Paediatr. 85 (8): 928–31. PMID 8863873.
  29. Jacobs JP, Konstantakos AK, Holland FW, Herskowitz K, Ferrer PL, Perryman RA (1994). "Surgical treatment for cardiac rhabdomyomas in children". Ann Thorac Surg. 58 (5): 1552–5. PMID 7979700.
  30. Staley BA, Vail EA, Thiele EA (January 2011). "Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs". Pediatrics. 127 (1): e117–25. doi:10.1542/peds.2010-0192. PMC 3010088. PMID 21173003.
  31. Germ cell tumors. Radiopedia(2015) http://radiopaedia.org/articles/cardiac-rhabdomyoma Accessed on January 25, 2016
  32. Zhang N, Zeng Z, Li S, Wang F, Huang P (August 2018). "High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors". Sci Rep. 8 (1): 12331. doi:10.1038/s41598-018-30648-7. PMC 6098067. PMID 30120321.
  33. Tiberio D, Franz DN, Phillips JR (2011). "Regression of a cardiac rhabdomyoma in a patient receiving everolimus". Pediatrics. 127 (5): e1335–7. doi:10.1542/peds.2010-2910. PMID 21464184.
  34. Wagner R, Riede FT, Seki H, Hornemann F, Syrbe S, Daehnert I; et al. (2015). "Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression Documented by Real Time 3D Echocardiography". Echocardiography. 32 (12): 1876–9. doi:10.1111/echo.13015. PMID 26199144.
  35. Öztunç F, Atik SU, Güneş AO (October 2015). "Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia". Cardiol Young. 25 (7): 1411–4. doi:10.1017/S1047951114002261. PMID 26339757.
  36. Amelia Souza A, de Araújo VC, Passador Santos F, Ferreira Martinez E, de Menezes Filho JF, Soares de Araujo N, Soares AB (2013). "Intraoral adult rhabdomyoma: a case report". Case Rep Dent. 2013: 741548. doi:10.1155/2013/741548. PMC 3833031. PMID 24288631.
  37. Dodat H, Paulhac JB, Macabeo V, Bouvier R (1987). "[Benign tumors of the posterior urethra in children. Apropos of an unusual case of rhabdomyoma of fetal type]". J Urol (Paris) (in French). 93 (1): 43–6. PMID 3031168.
  38. Pinho MM, de Carvalho E Castro J, Ramos RG (October 2013). "Adult rhabdomyoma of the larynx". Int Arch Otorhinolaryngol. 17 (4): 415–8. doi:10.1055/s-0033-1351671. PMC 4399195. PMID 25992049. Vancouver style error: missing comma (help)
  39. Norawat R, Sarkar D, Maybauer MO (2018). "Perioperative management of critical right ventricular inflow obstruction from right atrial rhabdomyoma". Ann Card Anaesth. 21 (4): 430–432. doi:10.4103/aca.ACA_233_17. PMC 6206783. PMID 30333341.